Can ITP Cause Blood Clots Even With Low Platelet Counts?

Yes, it is true—and it can be deeply counterintuitive and frightening. Even though Immune Thrombocytopenia (ITP) causes low platelet counts and an increased risk of bleeding, having the disease can actually modestly increase your relative risk of developing blood clots (thrombosis) compared to the general population ^[1].

While most people with ITP will not develop a blood clot, having a low platelet count does not completely protect you from one ^[2]. Some patients experience both bleeding and clotting risks simultaneously, with blood clots occurring even when platelet counts are very low ^[3].

⚠️ IMPORTANT SAFETY WARNING: When to Seek Emergency Care
If you experience any of the following symptoms, seek emergency medical care immediately. Do not wait for your next appointment, and do not self-start aspirin or any blood thinners without direct instruction from your doctor:

• Signs of a venous clot (lungs or legs): Sudden shortness of breath, chest pain, coughing up blood, or sudden swelling, pain, or warmth in one leg.
• Signs of an arterial clot (stroke or heart attack): Sudden weakness or numbness on one side of the face or body, difficulty speaking, vision changes, or severe chest pressure.
• Signs of serious bleeding: A sudden, severe “worst-ever” headache (which could signal bleeding in the brain) or heavy, uncontrolled bleeding.

The Paradox: Possible Contributors to Clotting

How can a clot form when you don’t have enough platelets? The answer involves a complex, rebalanced state in your blood and immune system. Researchers have identified several proposed mechanisms that are actively being studied as contributors to this risk ^[4]:

• Younger, Reactive Platelets: In ITP, the bone marrow pumps out new platelets to replace those destroyed by the immune system. These younger platelets may be more hyperactive and reactive, meaning they can clump together more easily even in small numbers ^[4][5].
• Platelet Microparticles: When platelets are broken down or activated, they release tiny fragments called microparticles. These microscopic pieces are being studied as possible contributors to a pro-clotting environment in the bloodstream ^[6].
• Inflammation and the Blood Vessels: ITP is an autoimmune condition involving inflammation. This chronic inflammation might activate the endothelium (the inner lining of your blood vessels), making the environment more prone to gathering clots ^[7].
• Antiphospholipid Antibodies: Some people with ITP test positive for antiphospholipid antibodies, which are associated with an increased clotting risk. However, a single positive test does not mean you have Antiphospholipid Syndrome (APS), as antibodies can be transient. Testing is not automatically needed for everyone and should be guided by your specific history and clinician ^[8].

How ITP Treatments Affect Clotting Risk

Managing ITP is a delicate balance. Some treatments provide critical bleeding-prevention benefits but are also observationally linked to increased clotting risks ^[9]. Never stop, start, or change your ITP medications on your own without speaking to your prescribing doctor.

• TPO-Receptor Agonists (TPO-RAs): Medications like eltrombopag and romiplostim stimulate the bone marrow to produce more platelets. They have an individualized but recognized association with higher rates of both venous and arterial blood clots ^[9][10].
• Splenectomy: Surgically removing the spleen is a recognized treatment for ITP, but it comes with an increased risk of blood clots. This risk is especially notable in the weeks and months immediately following the surgery ^[9][11].
• Corticosteroids and IVIG: Standard therapies used to calm the immune system, such as high-dose steroids and intravenous immunoglobulin (IVIG), have also been linked in observational studies to an increased risk of blood clots. However, this risk may partly be influenced by the severity of the patient’s underlying illness and other compounding health factors ^[9].

Additional Risk Factors Matter

Your individual risk of a blood clot varies and is often influenced by a combination of ITP-related factors and standard risk factors ^[9][12]. Important compounding factors include:

• Older age, obesity, or smoking
• High blood pressure, diabetes, or heart conditions (such as atrial fibrillation)
• A personal or family history of blood clots or cancer
• Temporary practical triggers: Recent surgery, hospitalization, immobility, long travel, pregnancy/postpartum status, central venous catheters, or taking estrogen-containing medications (like certain birth controls or hormone replacement therapies).

If a blood clot is confirmed, it is not simply left untreated because of your ITP. Treatment decisions require an urgent evaluation by a hematologist or specialist who will weigh the clot’s location and severity against your specific platelet levels, active bleeding, and ITP treatment plan to find the safest individualized approach ^[13][14].